ATG5 knockdown significantly reduces glucose and lactate uptake in lung tumors, leading to the impaired circulating metabolism and biosynthesis of TCA, as well as increased tumor T cell infiltration, which promotes T cell-mediated tumor killing and comediates antitumor effects. Here, ATG5 is linked to neoplasm.